Louise Collins

1.0k citations

31 papers · 805 indexed · h-index 15

Molecular Biology
Cellular and Molecular Neuroscience top 10%
Neurology top 5%
Neurology top 5%
Geophysics top 10%

Co-authors: André Toulouse Yvonne M. Nolan Gerard W. O’Keeffe Thomas J. Connor Aideen M. Sullivan Séan Wyatt Valerie A. Jackson J. Spratt
Topics: Parkinson's Disease Mechanisms and Treatments (13 papers)Nuclear Receptors and Signaling (9 papers)Nerve injury and regeneration (8 papers)
Cited by: Neurology Biological Psychiatry
Journals: SHILAP Revista de lepidopterologíaJournal of Geophysical Research Atmospheres Journal of Neurochemistry
Partner nations: Ireland United Kingdom Italy

In The Last Decade

Louise Collins

29 papers receiving 790 citations

Peers

Countries citing papers authored by Louise Collins

Since Specialization

Citations

This map shows the geographic impact of Louise Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Collins more than expected).

Fields of papers citing papers by Louise Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Collins. The network helps show where Louise Collins may publish in the future.

Co-authorship network of co-authors of Louise Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Collins. A scholar is included among the top collaborators of Louise Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Collins. Louise Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating Awareness of Pesticide Exposure as a Risk Factor for Parkinson’s Disease and Uptake of Exposure-Mitigating Behaviour in Farming Communities in Ireland 2025 ·Safety ·Lucy Collins,Éilis J. O’Reilly,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Louise Collins,Gerard W. O’Keeffe,Aideen M. Sullivan	0
2	The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson's disease 2025 ·Neuropharmacology ·(unknown),(unknown),Alex Morris,(unknown),Caitriona M. Guinane,Séan Wyatt,Louise Collins,Aideen M. Sullivan,Gerard W. O’Keeffe	3
3	Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes 2024 ·BMJ Open Diabetes Research & Care ·John Pemberton,Louise Collins,(unknown),Renuka Dias,Ruth Krone,Melanie Kershaw,Suma Uday	4
4	Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells 2022 ·Molecular Neurobiology ·Erin L. McCarthy,(unknown),(unknown),(unknown),Cathal McCarthy,Louise Collins,Aideen M. Sullivan,Gerard W. O’Keeffe	3
5	Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease 2021 ·Neural Regeneration Research ·Aideen M. Sullivan,Gerard W. O’Keeffe,(unknown),(unknown),Louise Collins	4
6	NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease 2021 ·Molecular Neurobiology ·(unknown),(unknown),Eszter Tuboly,(unknown),Gerard M. Moloney,(unknown),Cathal McCarthy,Louise Collins,Aideen M. Sullivan,Gerard W. O’Keeffe	8
7	Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration 2021 ·Molecular Neurobiology ·(unknown),Martin Lévesque,Aideen M. Sullivan,Louise Collins,Gerard W. O’Keeffe	7
8	The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease 2020 ·Neural Regeneration Research ·Louise Collins,(unknown),Aideen M. Sullivan,Gerard W. O’Keeffe	23
9	STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5 2020 ·iScience ·(unknown),(unknown),Séan Wyatt,(unknown),Louise Collins,Aideen M. Sullivan,Gerard W. O’Keeffe	13
10	Education and public engagement using an active research project: lessons and recipes from the SEA-SEIS North Atlantic Expedition's programme for Irish schools 2019 ·SHILAP Revista de lepidopterología ·Sergei Lebedev,(unknown),(unknown),(unknown),(unknown),(unknown),Daniel Farrell,David L. Stalling,Céline Tirel,Louise Collins,(unknown),(unknown),(unknown),(unknown),Christopher J. Bean,(unknown)	2
11	Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling 2019 ·Frontiers in Cell and Developmental Biology ·(unknown),Séan Wyatt,Daniela Mercatelli,Michele Morari,(unknown),Louise Collins,Aideen M. Sullivan,Gerard W. O’Keeffe	17
12	Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein 2019 ·Parkinsonism & Related Disorders ·(unknown),Aideen M. Sullivan,Gerard W. O’Keeffe,Louise Collins	16
13	Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism 2015 ·Molecular Neurobiology ·Louise Collins,(unknown),(unknown),Jimena Monzón‐Sandoval,Aideen M. Sullivan,Humberto Gutiérrez,Michele Morari,Gerard W. O’Keeffe	9
14	Canonical BMP–Smad Signalling Promotes Neurite Growth in Rat Midbrain Dopaminergic Neurons 2014 ·NeuroMolecular Medicine ·Shane V. Hegarty,Louise Collins,(unknown),Sarah L. Roche,Séan Wyatt,Aideen M. Sullivan,Gerard W. O’Keeffe	41
15	Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease 2014 ·SpringerPlus ·Louise Collins,(unknown),(unknown),Aideen M. Sullivan,Séan Wyatt,Gerard W. O’Keeffe,Yvonne M. Nolan,André Toulouse	3
16	Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult 2014 ·Molecular Neurobiology ·Louise Collins,(unknown),(unknown),Shane V. Hegarty,Aideen M. Sullivan,Gerard W. O’Keeffe	32
17	Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease 2014 ·Molecular Neurobiology ·Louise Collins,Eric J. Downer,André Toulouse,Yvonne M. Nolan	30
18	Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 as a Neuroprotective Agent: Promotion of the Morphological Development of Midbrain Dopaminergic Neurons 2013 ·NeuroMolecular Medicine ·Louise Collins,Gerard W. O’Keeffe,Caitríona M. Long-Smith,Séan Wyatt,Aideen M. Sullivan,André Toulouse,Yvonne M. Nolan	27
19	Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease 2012 ·Neuropharmacology ·Louise Collins,André Toulouse,Thomas J. Connor,Yvonne M. Nolan	238
20	Exposure of foetal neural progenitor cells to IL‐1β impairs their proliferation and alters their differentiation – a role for maternal inflammation? 2011 ·Journal of Neurochemistry ·Sean J. Crampton,Louise Collins,André Toulouse,Yvonne M. Nolan,Gerard W. O’Keeffe	65

About Louise Collins

Louise Collins is a scholar working on Cellular and Molecular Neuroscience, Neurology and Neurology, having authored 31 papers that have together received 805 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (13 papers), Nuclear Receptors and Signaling (9 papers) and Nerve injury and regeneration (8 papers). The work is most often cited by research in Neurology (173 citations), Biological Psychiatry (40 citations) and Neurology (229 citations). Louise Collins has collaborated with scholars based in Ireland, United Kingdom and Italy. Frequent co-authors include André Toulouse, Yvonne M. Nolan, Gerard W. O’Keeffe, Thomas J. Connor, Aideen M. Sullivan, Séan Wyatt, Valerie A. Jackson, J. Spratt, Alan G. Jones and Anna Avdeeva. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Geophysical Research Atmospheres and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact